Pseudophakic cystoid macular edema

Ophthalmologica

Volumn 227, Issue 2, 2012, Pages 61-67

  Lobo, Conceição ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Cataract surgery; Cystoid macular edema; Inflammatory mediators; Management

Indexed keywords

ACETAZOLAMIDE; ANGIOGENESIS INHIBITOR; ANTIGLAUCOMA AGENT; BEVACIZUMAB; BIMATROPOST; CORTICOSTEROID; LATANOPROST; NONSTEROID ANTIINFLAMMATORY AGENT; TRAVOPROST; UNCLASSIFIED DRUG; UNOPROSTONE;

ANGIOGRAPHY; CATARACT EXTRACTION; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG MEGADOSE; DRUG WITHDRAWAL; HUMAN; INCIDENCE; INFLAMMATION; NEODYMIUM LASER; OPHTHALMOSCOPY; PHACOEMULSIFICATION; PSEUDOPHAKIC CYSTOID MACULAR EDEMA; RETINA MACULA CYSTOID EDEMA; REVIEW; RISK FACTOR; SURGICAL RISK; TOPICAL TREATMENT; VITRECTOMY;

CATARACT EXTRACTION; HUMANS; INCIDENCE; MACULAR EDEMA; PSEUDOPHAKIA; RISK FACTORS;

EID: 84856422248     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000331277     Document Type: Review

References (92)

1. De Cross FC, Afshari NA: Perioperative antibiotics and anti-inflammatory agents in cataract surgery. Curr Opin Ophthalmol 2008;19:22-26.
2. Panchapakesan J, Rochtchina E, Mitchell P: Five-year change in visual acuity following cataract surgery in an older community: the Blue Mountains Eye Study. Eye 2004;18:278-282.
3. Linebarger EJ, Hardten DR, Shah GK, et al: Phacoemulsification and modern cataract surgery. Surv Ophthalmol 1999;44:123-147.
4. Gogate PM, Kulkarni SR, Krishnaiah S, et al: Safety and efficacy of phacoemulsification compared with manual small-incision cataract surgery by a randomized controlled clinical trial: six-week results. Ophthalmology 2005;112:869-874.
5. Riaz Y, Mehta JS, Wormald R, et al: Surgical interventions for age related cataract. Cochrane Database Syst Rev 2006; (4): C-graveOOI323.
6. O' Brien TP: Emerging guidelines for use of NSA-grave therapy to optimize cataract surgery patient care. Curr Med Res Opin 2005;21:1131-1137
7. correction 2005;21:1431-1432.
8. Rossetti L, Autelitano A: Cystoid macular edema following cataract surgery. Curr Opin Ophthalmol 2000;11:65-72.
9. Mohammadpour M, Jafarinasab MR, Javadi MA: Outcomes of acute postoperative inflammation after cataract surgery. Eur J Ophthalmol 2007;17:20-28.
10. Nelson ML, Martidis A: Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol 2003;14:39-43.
11. Irvine AR: A newly defined vitreous syndrome following cataract surgery, interpreted according to recent concepts of the structure of the vitreous. Am J Ophthalmol 1953;36:599-619.
12. Gass J-grave. Norton EW: Cystoid Macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic study. Arch Ophthalmol 1966;76:646-661.
13. Irvine AR: Cystoid maculopathy. Surv Ophthalmol 1976;21:1-17.
14. Ursell PG, Spalton DJ, Whitcup SM, Nussenblat RB: Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg 1999;25:1492-1497.
15. Hitchings RA, Chisholm IH, Bird AC: Aphakic macular edema: incidence and pathogenesis. Invest Ophthalmol Soc 1975;14:68-72.
16. Jaffe NS, Clayman HM, Jaffe MS: Cystoid macular edema after intracapsular and extracapsular extraction with and without an intraocular lens. Ophthalmology 1982;89:25-29.
17. Kraff MC, Sanders DR, Jampol LM, Lieberman HL: Effect of primary capsulotomy with extracapsular surgery on the incidence of pseudophakic cystoid macular edema. Am J Ophthalmol 1984;98:166-170.
18. Koch PS: Anterior vitrectomy; in Nordan LT, Maxwell WA, Davidson JA (eds): Surgical Rehabilitation of Vision: An Integrated Approach to Anterior Segment Surgery. London, Gower, 1992, chapter 17.
19. Powe NR, Schein O-grave, Gieser SC, et al: Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team. Arch Ophthalmol 1994;112:239-252.
20. Oshika T, Yoshimura K, Miyata N: Postsurgical inflammation after phacoemulsification and extracapsular extraction with soft or conventional intraocular lens implantation. J Cataract Refact Surg 1992;18:356-361.
21. Pande MV, Spalton DJ, Kerr-Muir MG, Marshall J: Postoperative inflammatory response to phacoemulsification and extracapsular cataract surgery: aqueous flare and cells. J Cataract Refract Surg 1996;22:770-774.
22. Kraff MC, Lieberman HL, Jampol LM, Sanders DR: Effect of a pupillary light occluder on cystoid macular edema. J Cataract Refract Surg 1989;15:658-660.
23. Nagpal M, Nagpal K, Nagpal PN: Postcataract cystoid macular edema. Ophthalmol Clin North Am 2001;14:651-659.
24. Stern AL, Taylor DM, Dalburg LA, et al: Pseudophakic cystoid maculopathy: a study of 50 cases. Ophthalmology 1981;88:942-946.
25. Loewenstein A, Zur D: Postsurgical cystoid macular edema; in Coscas G (ed): Macular Edema. Dev Ophthal. Basel, Karger, 2010; vol 47, pp 148-159.
26. Frost NA, Sparrow JM, Strong NP, Rosenthal AR: Vitreous loss in planned extracapsular cataract extraction does lead to a poorer visual outcome. Eye 1995;9:446-451.
27. Flach AJ: The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998;96:557-634.
28. Balent A, Civerchia LL, Mohamadi P: Visual outcomes of cataract extraction and lens implantation complicated by vitreous loss. J Cataract Refract Surg 1988;14:158-160.
29. Bergman M, Laatikainen L: Cystoid macular oedema after complicated cataract surgery and implantation of an anterior chamber lens. Acta Ophthalmol (Copenh) 1994;72:178-180.
30. Blomquist PH, Rugwani RM: Visual outcomes after vitreous loss during cataract surgery performed by residents. J Cataract Refract Surg 2002;28:847-852.
31. Ah-Fat FG, Sharma MK, Majid MA, Yang YC: Vitreous loss during conversion from conventional extracapsular cataract extraction to phacoemulsification. J Cataract Refract Surg 1998;24:801-805.
32. Morel C, Roman S, Metge F, et al: Surgery of intravitreous nuclear luxations post-phacoemulsification (in French). J Fr Ophthalmol 1998;21:170-175.
33. Ray S, Amico DJ: Pseudophakic cystoid macular edema. Semin Ophthalmol 2002;17:167-180.
34. Spaide RF, Yannuzzi LA, Sisco LJ: Chronic cystoid macular edema and predictors of visual acuity. Ophthalmic Surg 1993;24:262-267.
35. Borne MJ, Tasman W, Regillo C, et al: Outcomes of vitrectomy for retained lens fragments. Ophthalmology 1996;103:971-976.
36. Kapusta MA, Chen JC, Lam WC: Outcomes of dropped nucleous during phacoemulsification. Ophthalmology 1996;103:1184-1187.
37. Rossetti A, Doro D: Retained intravitreal lens fragments after phacoemulsification: complications and visual outcome in vitrectomized and nonvitrectomized eyes. J Cataract Refract Surg 2002;28:310-315.
38. Cohen SM, Davis A, Cukrowski C: Cystoid macular edema and pars plana vitrectomy for retained lens fragments. J Cataract Refract Surg 2006;32:1521-1526.
39. Sheidow TG, Gonder JR: Cystoid macular edema following combined phacoemulsification and vitrectomy in macular hole. Retina 1998;18:510-514.
40. Jampol LM: Aphakic cystoid macular edema: a hypothesis. Arch Ophthalmol 1985;103:1134-1135.
41. Callanan D, Fellman RL, Savage JA: Latanoprostassociated cystoid macular edema. Am J Ophthalmol 1998;126:134-135.
42. Miyake K, Ota I, Maekubo K, et al: Latanoprost accelerates disruption of the bloodaqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol 1999;117:34-40.
43. Moroi SE, Gottfredsdottir MS, Schteingart MT, et al: Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology 1999;106:1024-1029.
44. Ayyala RS, Cruz DA, Margo CE, et al: Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes. Am J Ophthalmol 1998;126:602-604.
45. Wand M, Gaudio AR: Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol 2002;133:403-405.
46. Pollack A, Leiba H, Bukelman A, Oliver M: Cystoid macular edema following cataract extraction in patients with diabetes. Br J Ophthalmol 1992;76:221-224.
47. Schmier JK, Halpern MT, Covert DW, et al: Evaluation of cost for cystoid macular edema among patients after cataract surgery. Retina 2007;27:621-628.
48. Henricsson M, Heijl A, Janzon L: Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol 1996;80:789-793.
49. Dowler JGF, Hykin PG, Lightman SL, et al: Visual acuity following extracapsular cataract extraction in diabetes: a meta-analysis. Eye 1995;9:313-317.
50. Schatz H, Atienza D, McDonald HR, et al: Severe diabetic retinopathy after cataract surgery. Am J Ophthalmol 1994;117:314-321.
51. Dowler JGF, Sehmi KS, Hykin PG, et al: The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 1999;106:663-668.
52. Okhravi N, Lightman SL, Towler HM: Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology 1999;106:710-722.
53. Hooper PL, Rao NA, Smith RE: Cataract extraction in uveitis patients. Surv Ophthalmology 1990;35:120-144.
54. Foster RE, Lowder CY, Meisler OM, Zakov ZN: Extracapsular cataract extraction and posterior chamber intraocular lens implantation in uveitis patients. Ophthalmology 1992;99:1234-1241.
55. Schepens CL, Avila MP, Jalkh AE, et al: The role of vitreous in cystoid macular edema. Surv Ophthalmol 1984;28:499-504.
56. Cunha-Vaz JG, Travassos A: Breakdown of the blood-retinal barriers and cystoid macular edema. Survey Ophthalmol 1984;28:485-492.
57. Miyake K: Vitreous fluorophotometry in aphakic or pseudophakic eyes with persistent cystoid macular edema. Jpn J Ophthalmol 1985;29:146-152.
58. Smith RT, Campbell CJ, Koester CJ, et al: The barrier function in extracapsular cataract surgery. Ophthalmology 1990;97:90-95.
59. Miyake K: Prevention of cystoid macular edema after lens extraction by topical indomethacin. I. A preliminary report. Albrecht von Grafes Arch Klin Exp Ophthalmol 1977;203:81-88.
60. Miyake K: Prevention of cystoid macular edema after lens extraction by topical indomethacin. II. A control study in bilateral extractions. Jpn J Ophthalmol 1978;22:80-94.
61. Jampol LM: Cystoid macular edema following cataract surgery. Arch Ophthalmol 1988;106:894-895.
62. Stark WJ, Maumenee AE, Fagadau W, et al: Cystoid macular edema in pseudophakia. Surv Ophthalmol 1984;28:442-445.
63. Bito LZ: Prostaglandins: old concepts and new perspectives. Arch Ophthalmol 1987;105:1036-1039.
64. Tso MOM: Pathophysiology of cystoid macular edema. Ophthalmology 1982;89:902-915.
65. Miyake K, Ibaraki N: Prostaglandins and cystoid macular edema. Surv Ophthalmol 2002;47(suppl 1): S203-S218.
66. Augustin A, Loewenstein A, Kuppermann B-grave: General pathophysiology; in Coscas G (eds): Macular Edema. Dev Ophthalmol. Basel, Karger, 2010, vol 47, pp 10-26.
67. Mentes J, Erakgun T, Afrashi F, et al: Incidence of cystoid macular edema after uncomplicated phacoemulsification. Ophthalmologica 2003;217:408-412.
68. Asano S, Kensaku M, Ota I, et al: Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation. Multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%. J Cataract Refract Surg 2008, 34:57-63.
69. Rossetti L, Chaudhwi H, Dickersin K: Medical prophylaxis and treatment of cystoid macular edema after cataract surgery: the results of a meta-analysis. Ophthalmology 1998;105:397-405.
70. Sivaprasad S, Bunce C, Wormald R: Nonsteroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. Br J Ophthalmol 2005;89:1420-1422.
71. Kraff MC, Sanders DR, Jampol LM, et al: Factors affecting pseudophakic cystoid macular edema: five randomized trials. J Am Intraoc Implant Soc 1985;11:380-385.
72. Henderson BA, Kim JY, Ament CS, et al: Clinical pseudophakic cystoid macular edema: risk factors for development and duration after treatment. J Cataract Refract Surg 2007;33:1550-1558.
73. Kim A, Stark WJ: Are topical NSAI-graves needed for routine cataract surgery? Am J Ophthalmol 2008;146:554-560.
74. Arciere ES, Santana A, Rocha FN: Bloodaqueous barrier changes after the use of prostaglandins analogues in patients with pseudophakia and aphakia. Arch Ophthalmol 2005;123:186-192.
75. Lobo CL, Faria PM, Soares MA, et al: Macular alterations after small incision cataract surgery. J Cataract Refract Surg 2004;30:752-760.
76. Hee MR, Izatt JA, Swanson EA, et al: Optical coherence tomography of the human retina. Arch Ophthalmol 1995;113:325-332.
77. Perente I, Utine CA, Ozturker C, et al: Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res 2007;32:241-247.
78. Biro Z, Balla Z, Kovacs B: Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation. Eye 2008;22:8-12.
79. Almeida DR, Johnson D, Hollands H, et al: Effect of prophylactic nonsteroidal anti-inflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. J Cataract Refract Surg 2008;34:64-69.
80. Salomon L-grave: Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen - CME study group I. J Cataract Refract Surg 1995;21:73-81.
81. Cervantes-Costes G, Sánchez-Castro Y, Mendoza-Schuster E, et al: Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Clin Ophthalmol 2009;3:219-226.
82. Wolf EJ, Braunstein A, Shih C, et al: Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac. J Cataract Refreact Surg 2007;33:1546-1549.
83. Heier JS, Topping TM, Baumann W, et al: Ketorolac versus prednisolone versus combination therapy in treatment of acute pseudophakic cystoid macular edema. Am Acad Ophthalmology 2000;107:2034-2038.
84. Flach AJ: Nonsteroidal anti-inflammatory drugs; in Tasman W (ed): Duane's Foundations of Clinical Ophthalmology. Philadelphia, Lippincott, 1994, pp 1-32.
85. Jonas JB, Kreissing I, Segenring RF: Intravitreal triancinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 2003;136:384-386.
86. Boscia F, Furino C, Dammaco R, et al: Intravitreal triancinolone acetonide in refractory pseudophakic cystoid macular edema: functional and anatomic results. Eur J Ophthalmol 2005;15:89-95.
87. Conway M-grave, Canakis C, Livir-Rallatos C, et al: Intravitreal triancinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg 2003;29:27-33.
88. Tranos PG, Wickremasinghe SS, Stangos NT, et al: Macular edema. Surv Ophthalmol 2004;5:470-490.
89. Catier A, Tadayoni R, Massin P, et al: Advantages of acetazolamide associated with antiinflammatory medications in postoperative treatment of macular edema (in French). J Fr Ophthalmol 2005;28:1027-1031.
90. Spitzer MS, Ziemssen F, Yoeruek E, et al: Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg 2008;34:70-75.
91. Steinert RF, Wasson PI: Neodymium: YAG laser anterior vitreolysis for Irvine-Gass cystoid macular edema. J Cataract Refract Surg 1989;15:304-307.
92. Alió J, Bodaghi B, Tassignon MJ: Guidelines for managing post-cataract surgery inflammation. Can we reach a consensus? Ophthalmol Times Europe 2008; (suppl Nov): 1-11.